New molecular entity: Vesicare, Yamanouchi/GlaxoSmithKline solifenacin

Geriatrics. 2005 Jan;60(1):18.
No abstract available

MeSH terms

  • Administration, Oral
  • Drug Approval
  • Drug Interactions
  • Humans
  • Quinuclidines / therapeutic use*
  • Solifenacin Succinate
  • Tetrahydroisoquinolines / therapeutic use*
  • United States
  • United States Food and Drug Administration
  • Urinary Bladder Diseases / drug therapy*

Substances

  • Quinuclidines
  • Tetrahydroisoquinolines
  • Solifenacin Succinate